Drug Trial Radar · NCT06849973
To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome
Last checked: Nov 19, 2026Latest source record: Feb 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
187
Actual
Start
Mar 15, 2024
Primary completion
Nov 22, 2024
Study completion Jan 28, 2025
Sponsor
- Lead sponsor
- Biomed Industries, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 27, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 5 years, up to 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To study the efficacy \& safety of oral Bionetide versus placebo in girls and women with Rett syndrome
Conditions
- Rett Syndrome
Interventions
Drug: BionetideDrug
NA-921 (Bionetide) solution administered based on the subject's weight at Baseline, twice daily for 12 weeks
PlaceboDrug
NA-921 (Bionetide) placebo solution administered based on the subject's weight at Baseline, twice daily for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rett Syndrome Behavior Questionnaire (RSBQ) Total Score - Change From Baseline to Week 12Time frame: Baseline and Week 12
- Clinical Global Impression-Improvement (CGI-I) Score at Week 12Time frame: 12 Weeks Treatment Duration
Locations
16 sites in 2 countries. Site status is shown where the registry gives one.
Biomed Testing Facility # BIO-04-92093
La Jolla, California
Biomed Testing Facility # BIO-03-90095
Los Angeles, California
Biomed Testing Facility # BIO-02-95817
Sacramento, California
Biomed Testing Facility # BIO-01-94104
San Francisco, California
Biomed Testing Facility #BIO-05-80042
Aurora, Colorado
Biomed Testing Facility #BIO-06-60612
Chicago, Illinois
Maryland Locations Biomed Testing Facility #BIO-7-21205
Baltimore, Maryland
Biomed Testing Facility #BIO-8-02115
Boston, Massachusetts
Biomed Testing Facility #BIO-9-10467
The Bronx, New York
Biomed Testing Facility #BIO-10-44195
Cleveland, Ohio
Biomed Testing Facility #BIO-11-77030
Houston, Texas
Biomed Testing Facility #BIO-12-98105
Seattle, Washington
Biomed Research Unit-BIO-16-NSW
Camperdown, New South Wales, Australia
Biomed Research Unit-BIO-15
Sydney, New South Wales, Australia
Biomed Research Unit-BIO-13-VIC-3084 Heidelberg West, Victoria, Australia, 3084
Heidelberg West, Victoria, Australia
Biomed Research Unit- BIO-14-VIC 3010
Parkville, Victoria, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.